Holdings of T. Rowe Price Health Sciences Fund, Inc.
T. ROWE PRICE HEALTH SCIENCES FUND, INC. ·168 declared positions · as of Mar 31, 2026
Original filing · Net assets 10.9B $ · Ten largest lines: 42.2 % of the equity sleeve
Sector breakdown
- Health care 67.2 %
- Industrials 0.7 %
- Materials 0.5 %
- Consumer discretionary 0.2 %
- Unattributed 31.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.8 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 88.3 %
- GB 3.4 %
- NL 3.3 %
- BM 1.4 %
- HK 1.3 %
- JP 0.6 %
- KY 0.5 %
- FR 0.5 %
- CH 0.2 %
- DK 0.2 %
- SG 0.2 %
- VG 0.1 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 148 | 9B $ | 88.34 % |
| GB | 2 | 348.8M $ | 3.43 % |
| NL | 3 | 332.1M $ | 3.26 % |
| BM | 2 | 138M $ | 1.36 % |
| HK | 1 | 129.2M $ | 1.27 % |
| JP | 1 | 62.9M $ | 0.62 % |
| KY | 4 | 55.2M $ | 0.54 % |
| FR | 2 | 53.5M $ | 0.53 % |
| CH | 1 | 24.1M $ | 0.24 % |
| DK | 1 | 16.4M $ | 0.16 % |
| SG | 1 | 15.3M $ | 0.15 % |
| VG | 1 | 10.4M $ | 0.10 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co | 1,200,478 | 1.1B $ | 10.14 % |
| Thermo Fisher Scientific Inc | 900,979 | 442.9M $ | 4.07 % |
| Intuitive Surgical Inc | 863,221 | 397.9M $ | 3.65 % |
| Stryker Corp | 1,147,522 | 377.1M $ | 3.46 % |
| Merck & Co Inc | 3,116,392 | 374.9M $ | 3.44 % |
| AstraZeneca PLC | 1,751,235 | 345.4M $ | 3.17 % |
| UnitedHealth Group Inc | 1,242,865 | 336.3M $ | 3.09 % |
| Argenx SE | 435,310 | 317.9M $ | 2.92 % |
| AbbVie Inc | 1,423,341 | 309.6M $ | 2.84 % |
| Regeneron Pharmaceuticals, Inc. | 373,226 | 288.4M $ | 2.65 % |
| Gilead Sciences Inc | 2,034,836 | 283.6M $ | 2.60 % |
| Johnson & Johnson | 1,088,355 | 266M $ | 2.44 % |
| Vertex Pharmaceuticals Inc | 591,295 | 264M $ | 2.42 % |
| Danaher Corp | 1,175,471 | 222.9M $ | 2.05 % |
| Alnylam Pharmaceuticals Inc | 531,894 | 176M $ | 1.62 % |
| Revolution Medicines Inc | 1,519,722 | 147.8M $ | 1.36 % |
| United Therapeutics Corp | 246,943 | 146.4M $ | 1.34 % |
| BeOne Medicines Ltd | 5,757,796 | 129.2M $ | 1.19 % |
| Roivant Sciences Ltd | 4,447,673 | 123.2M $ | 1.13 % |
| Protagonist Therapeutics Inc | 1,142,059 | 120.4M $ | 1.11 % |
| Insmed Inc | 702,695 | 114.9M $ | 1.05 % |
| Summit Therapeutics Inc | 5,948,323 | 112.8M $ | 1.04 % |
| Natera Inc | 561,746 | 112.3M $ | 1.03 % |
| Tenet Healthcare Corp | 580,102 | 109.5M $ | 1.00 % |
| BrightSpring Health Services Inc | 2,514,077 | 107.1M $ | 0.98 % |
| Amgen Inc | 303,722 | 106.9M $ | 0.98 % |
| Boston Scientific Corp | 1,603,771 | 100.6M $ | 0.92 % |
| HCA Healthcare Inc | 206,215 | 97.6M $ | 0.90 % |
| Guardant Health Inc | 1,055,988 | 97.5M $ | 0.90 % |
| CVS Health Corp | 1,310,339 | 94.1M $ | 0.86 % |
| Kymera Therapeutics Inc | 1,002,367 | 83.5M $ | 0.77 % |
| Cigna Group/The | 300,304 | 80.1M $ | 0.74 % |
| CG oncology Inc | 1,108,573 | 75M $ | 0.69 % |
| Cardinal Health, Inc. | 348,232 | 73.6M $ | 0.68 % |
| Elevance Health Inc | 244,278 | 71.5M $ | 0.66 % |
| Krystal Biotech Inc | 273,451 | 70.6M $ | 0.65 % |
| Scholar Rock Holding Corp | 1,369,780 | 67.3M $ | 0.62 % |
| Ionis Pharmaceuticals Inc | 882,823 | 66.3M $ | 0.61 % |
| Bridgebio Pharma Inc | 864,149 | 64.2M $ | 0.59 % |
| Chugai Pharmaceutical Co Ltd | 1,141,000 | 62.9M $ | 0.58 % |
| Structure Therapeutics Inc | 1,273,207 | 61.4M $ | 0.56 % |
| Praxis Precision Medicines Inc | 189,301 | 61M $ | 0.56 % |
| Celcuity Inc | 531,000 | 60.6M $ | 0.56 % |
| Royalty Pharma PLC | 1,241,743 | 59.6M $ | 0.55 % |
| Cencora Inc | 179,717 | 56.5M $ | 0.52 % |
| CENTESSA PHARMACEUTICALS PLC | 1,367,577 | 54.3M $ | 0.50 % |
| Vera Therapeutics Inc | 1,235,806 | 49.7M $ | 0.46 % |
| Nuvalent Inc | 459,791 | 47.1M $ | 0.43 % |
| Apogee Therapeutics Inc | 555,098 | 46.7M $ | 0.43 % |
| Abivax SA | 407,954 | 45.4M $ | 0.42 % |
| Edwards Lifesciences Corp | 562,277 | 45M $ | 0.41 % |
| Cytokinetics Inc | 663,136 | 43.7M $ | 0.40 % |
| Incyte Corp | 460,840 | 43.4M $ | 0.40 % |
| Spyre Therapeutics Inc | 854,145 | 43.1M $ | 0.40 % |
| Dianthus Therapeutics Inc | 482,750 | 40.5M $ | 0.37 % |
| Crinetics Pharmaceuticals Inc | 1,094,456 | 39.8M $ | 0.36 % |
| Tenax Therapeutics Inc | 2,481,066 | 39.7M $ | 0.36 % |
| Madrigal Pharmaceuticals Inc | 74,723 | 39.1M $ | 0.36 % |
| Immunome Inc | 1,665,614 | 36.4M $ | 0.33 % |
| IQVIA Holdings Inc | 207,553 | 35.4M $ | 0.32 % |
| Kodiak Sciences Inc | 921,511 | 35.1M $ | 0.32 % |
| Caris Life Sciences Inc | 1,909,867 | 34.1M $ | 0.31 % |
| Belite Bio Inc | 207,862 | 33.1M $ | 0.30 % |
| Monte Rosa Therapeutics Inc | 1,869,110 | 30.7M $ | 0.28 % |
| Terns Pharmaceuticals Inc | 557,042 | 29.4M $ | 0.27 % |
| Axsome Therapeutics Inc | 163,910 | 27.7M $ | 0.25 % |
| Moderna Inc | 527,555 | 26.8M $ | 0.25 % |
| Alumis Inc | 1,188,623 | 26.2M $ | 0.24 % |
| Beam Therapeutics Inc | 1,093,992 | 26.1M $ | 0.24 % |
| Alignment Healthcare Inc | 1,475,585 | 26M $ | 0.24 % |
| West Pharmaceutical Services Inc | 97,625 | 24.5M $ | 0.22 % |
| Sonova Holding AG | 105,533 | 24.1M $ | 0.22 % |
| Revvity Inc | 274,277 | 24M $ | 0.22 % |
| IDEXX Laboratories Inc | 42,552 | 23.9M $ | 0.22 % |
| Oruka Therapeutics Inc | 476,018 | 23.3M $ | 0.21 % |
| ORIC Pharmaceuticals Inc | 1,740,383 | 22.1M $ | 0.20 % |
| Sionna Therapeutics Inc | 547,443 | 21.9M $ | 0.20 % |
| MBX Biosciences Inc | 721,309 | 21.5M $ | 0.20 % |
| McKesson Corp | 24,522 | 21.2M $ | 0.19 % |
| Rhythm Pharmaceuticals Inc | 241,658 | 21M $ | 0.19 % |
| Billiontoone Inc | 264,475 | 20.9M $ | 0.19 % |
| Mirum Pharmaceuticals Inc | 224,930 | 20.8M $ | 0.19 % |
| Erasca Inc | 1,247,913 | 20.2M $ | 0.19 % |
| Immunocore Holdings PLC | 643,368 | 19.4M $ | 0.18 % |
| Palvella Therapeutics Inc | 153,120 | 19.1M $ | 0.18 % |
| Arrowhead Pharmaceuticals Inc | 301,270 | 18.9M $ | 0.17 % |
| Nurix Therapeutics Inc | 1,215,025 | 18.8M $ | 0.17 % |
| Rapport Therapeutics Inc | 601,105 | 18.8M $ | 0.17 % |
| Vaxcyte Inc | 314,645 | 18.3M $ | 0.17 % |
| Centene Corp | 529,331 | 17.3M $ | 0.16 % |
| Bio-Rad Laboratories Inc | 60,717 | 16.9M $ | 0.16 % |
| MoonLake Immunotherapeutics | 887,029 | 16.5M $ | 0.15 % |
| Novo Nordisk A/S | 446,869 | 16.4M $ | 0.15 % |
| WaVe Life Sciences Ltd | 2,107,233 | 15.3M $ | 0.14 % |
| Kestra Medical Technologies Ltd | 744,410 | 14.8M $ | 0.14 % |
| Stoke Therapeutics Inc | 452,134 | 14.7M $ | 0.14 % |
| Encompass Health Corp | 151,360 | 14.6M $ | 0.13 % |
| BEONE MEDICINES LTD | 49,225 | 14.6M $ | 0.13 % |
| Charles River Laboratories International Inc | 79,633 | 13.7M $ | 0.13 % |
| Celldex Therapeutics Inc | 422,316 | 13.4M $ | 0.12 % |